Stephan-Nicollas M C G Oliveira

发表

Improved anticoagulant effect of fucosylated chondroitin sulfate orally administered as gastroresistant tablets

P. A. Mourão, G. R. Santos, Roberto J. C. Fonseca, 2017, Thrombosis and Haemostasis.

Pharmacokinetic, Hemostatic, and Anticancer Properties of a Low-Anticoagulant Bovine Heparin

P. Mourão, E. Vilanova, A. Tovar, 2022, TH open : companion journal to thrombosis and haemostasis.

Structure and haemostatic effects of generic versions of enoxaparin available for clinical use in Brazil: Similarity to the original drug

P. A. Mourão, B. C. Vairo, B. Glauser, 2012, Thrombosis and Haemostasis.

Effects of oversulfated and fucosylated chondroitin sulfates on coagulation

V. Pomin, P. A. Mourão, I. Araujo, 2010, Thrombosis and Haemostasis.

Structural and functional analyses of biosimilar enoxaparins available in Brazil

I. N. Queiroz, V. Pomin, P. A. Mourão, 2014, Thrombosis and Haemostasis.

Is the antithrombotic effect of sulfated galactans independent of serpin?

I. N. Queiroz, V. Pomin, P. A. Mourão, 2014, Journal of thrombosis and haemostasis : JTH.

A unique fucosylated chondroitin sulfate type II with strikingly homogeneous and neatly distributed &agr;-fucose branches

A. Valente, P. Mourão, A. Tovar, 2018, Glycobiology.

Update on Brazilian biosimilar enoxaparins

P. Mourão, A. Tovar, E. Vilanova, 2016, Expert review of hematology.

Heparin from bovine intestinal mucosa: Glycans with multiple sulfation patterns and anticoagulant effects

A. Tovar, P. A. Mourão, B. C. Vairo, 2012, Thrombosis and Haemostasis.

Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities

N. Benevides, F. R. Melo, Maria G. Pereira, 2008, Thrombosis and Haemostasis.